I agree it seems glaringly obvious that the remaining x 3 will have success, hard to see how there would be different side effects similarly sized groups for each trail.
Furthermore re phase 3, Jon seemed extremely confident that there is really high chance of success moving forward from this point from PMS based on phase 2 data being better that what could have been wished for!
NEU Price at posting:
$23.96 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)